Banco de Chile arrives at its June 10 earnings release carrying a meaningful analyst downgrade fresh in the market's memory — and a stock that has already felt the weight of it.
The most consequential pre-earnings development came two weeks ago. UBS slashed its price target on BCH from $48 to $39 on May 22, maintaining a Neutral rating. The move landed when the stock was trading near current levels, making it one of the cleaner signals about near-term Street caution. JP Morgan and Goldman Sachs had been steadily lifting targets through late 2025 — from $30 to $36, and from $31 to $35, respectively — but UBS's sharp reversal cuts against that recent optimism. The Street is largely parked at Neutral across the board, with two buys and six holds, reflecting a consensus that BCH is fairly valued at best, and vulnerable at worst.
The fundamental case is genuinely mixed. On one hand, the bank carries an attractive dividend score in the 80th percentile and is forecast to grow forward earnings at an above-average pace — the 12-month forward EPS growth estimate ranks in the 77th percentile. Return on equity of roughly 19% and a net income margin above 42% last quarter speak to a well-run franchise. On the other hand, quarterly revenue contracted nearly 8% year-on-year, and the valuation context is complicated by currency considerations. The P/E multiple derived from the ADR and USD-reported financials is difficult to reconcile cleanly with the underlying Chilean peso earnings base; treat any simple multiple comparison with caution.
The lending market tells a calmer story than the price action implies. Short interest has risen about 45% over the past month in share terms — from roughly 700,000 to just over 1 million shares — but with no free-float percentage available for BCH's ADR structure, the absolute level remains modest in context. Borrow costs are low at 0.58% annualised and have barely moved. Availability is firm at 145%, meaning nearly one and a half shares remain available to borrow for every one already lent out. There is no squeeze pressure visible in the lending market.
Options positioning leans very slightly bullish, not defensive. The put/call ratio is 0.04, running marginally below its 20-day average. For an ADR with limited options liquidity, however, the PCR carries less informational weight than it would for a more heavily traded name, and the near-static readings across recent weeks suggest the options market is not actively pricing a directional view into the print.
Tuesday's release will test whether the underlying Chilean banking franchise can demonstrate earnings resilience sufficient to re-anchor analyst targets — or whether UBS's sharp downward revision proves the first move in a broader reset.
See the live data behind this article on ORTEX.
Open BCH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
